186.59
[1]. Li Y, et al. Discovery of MD-22 as a First-in-Class, Highly Potent, and Efficacious Proteolysis Targeting Chimera Murine Double Minute 2 Degrader Capable of Achieving Complete and Durable Tumor Regression. J Med Chem. 2019 Jan 2;62(2):8-66.
![]()